Menu
← Oncology Approval Tracker
FDA DECISION ·
Opdivo
nivolumab · Bristol Myers Squibb
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adults with relapsed or refractory classical Hodgkin lymphoma after at least three lines of systemic therapy that include autologous stem-cell transplant.
LAMPGEN ANALYSIS
Why it matters
This converts a later-line accelerated indication. Count prior therapy lines and note transplant history when describing who falls within the approved population.
What research teams should watch
Review how each prior line and the autologous transplant were documented. Keep later-line evidence distinct from the randomized first-line combination study.
PRIMARY RECORDS